Ritlecitinib Demonstrates Effectiveness in Subgroup Analysis of Asian Patients

News
Article
At week 24, the proportion of Asian patients achieving significant hair regrowth (SALT ≤20) was substantially higher in ritlecitinib treatment groups than in placebo groups.
While the global prevalence of alopecia areata (AA) i
Read more...